180 related articles for article (PubMed ID: 24008831)
1. Oxidizing effects of exogenous stressors in Huntington's disease knock-in striatal cells--protective effect of cystamine and creatine.
Ribeiro M; Silva AC; Rodrigues J; Naia L; Rego AC
Toxicol Sci; 2013 Dec; 136(2):487-99. PubMed ID: 24008831
[TBL] [Abstract][Full Text] [Related]
2. Glutathione redox cycle dysregulation in Huntington's disease knock-in striatal cells.
Ribeiro M; Rosenstock TR; Cunha-Oliveira T; Ferreira IL; Oliveira CR; Rego AC
Free Radic Biol Med; 2012 Nov; 53(10):1857-67. PubMed ID: 22982598
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of 3-alkyl luteolin derivatives are mediated by Nrf2 transcriptional activity and decreased oxidative stress in Huntington's disease mouse striatal cells.
Oliveira AM; Cardoso SM; Ribeiro M; Seixas RS; Silva AM; Rego AC
Neurochem Int; 2015 Dec; 91():1-12. PubMed ID: 26476055
[TBL] [Abstract][Full Text] [Related]
4. Cystamine increases L-cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation.
Fox JH; Barber DS; Singh B; Zucker B; Swindell MK; Norflus F; Buzescu R; Chopra R; Ferrante RJ; Kazantsev A; Hersch SM
J Neurochem; 2004 Oct; 91(2):413-22. PubMed ID: 15447674
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-124 targets CCNA2 and regulates cell cycle in STHdh(Q111)/Hdh(Q111) cells.
Das E; Jana NR; Bhattacharyya NP
Biochem Biophys Res Commun; 2013 Jul; 437(2):217-24. PubMed ID: 23796713
[TBL] [Abstract][Full Text] [Related]
6. Calcineurin is involved in the early activation of NMDA-mediated cell death in mutant huntingtin knock-in striatal cells.
Xifró X; García-Martínez JM; Del Toro D; Alberch J; Pérez-Navarro E
J Neurochem; 2008 Jun; 105(5):1596-612. PubMed ID: 18221365
[TBL] [Abstract][Full Text] [Related]
7. FK506 ameliorates cell death features in Huntington's disease striatal cell models.
Rosenstock TR; de Brito OM; Lombardi V; Louros S; Ribeiro M; Almeida S; Ferreira IL; Oliveira CR; Rego AC
Neurochem Int; 2011 Oct; 59(5):600-9. PubMed ID: 21703318
[TBL] [Abstract][Full Text] [Related]
8. Insulin and IGF-1 improve mitochondrial function in a PI-3K/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington's disease knock-in striatal cells.
Ribeiro M; Rosenstock TR; Oliveira AM; Oliveira CR; Rego AC
Free Radic Biol Med; 2014 Sep; 74():129-44. PubMed ID: 24992836
[TBL] [Abstract][Full Text] [Related]
9. Probucol modulates oxidative stress and excitotoxicity in Huntington's disease models in vitro.
Colle D; Hartwig JM; Soares FA; Farina M
Brain Res Bull; 2012 Mar; 87(4-5):397-405. PubMed ID: 22245028
[TBL] [Abstract][Full Text] [Related]
10. Metabolic state determines sensitivity to cellular stress in Huntington disease: normalization by activation of PPARγ.
Jin YN; Hwang WY; Jo C; Johnson GV
PLoS One; 2012; 7(1):e30406. PubMed ID: 22276192
[TBL] [Abstract][Full Text] [Related]
11. Acute exposure to chlorpyrifos caused NADPH oxidase mediated oxidative stress and neurotoxicity in a striatal cell model of Huntington's disease.
Dominah GA; McMinimy RA; Kallon S; Kwakye GF
Neurotoxicology; 2017 May; 60():54-69. PubMed ID: 28300621
[TBL] [Abstract][Full Text] [Related]
12. Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin.
Jin YN; Yu YV; Gundemir S; Jo C; Cui M; Tieu K; Johnson GV
PLoS One; 2013; 8(3):e57932. PubMed ID: 23469253
[TBL] [Abstract][Full Text] [Related]
13. Insulin and IGF-1 regularize energy metabolites in neural cells expressing full-length mutant huntingtin.
Naia L; Ribeiro M; Rodrigues J; Duarte AI; Lopes C; Rosenstock TR; Hayden MR; Rego AC
Neuropeptides; 2016 Aug; 58():73-81. PubMed ID: 26876526
[TBL] [Abstract][Full Text] [Related]
14. Differential proteomic and genomic profiling of mouse striatal cell model of Huntington's disease and control; probable implications to the disease biology.
Choudhury KR; Das S; Bhattacharyya NP
J Proteomics; 2016 Jan; 132():155-66. PubMed ID: 26581643
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of Bim contributes to the potentiation of serum deprivation-induced apoptotic cell death in Huntington's disease knock-in striatal cell line.
Kong PJ; Kil MO; Lee H; Kim SS; Johnson GV; Chun W
Neurol Res; 2009 Feb; 31(1):77-83. PubMed ID: 18691453
[TBL] [Abstract][Full Text] [Related]
16. The common inhaled anesthetic isoflurane increases aggregation of huntingtin and alters calcium homeostasis in a cell model of Huntington's disease.
Wang Q; Liang G; Yang H; Wang S; Eckenhoff MF; Wei H
Toxicol Appl Pharmacol; 2011 Feb; 250(3):291-8. PubMed ID: 21059370
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of system xc(-) expression induced by mutant huntingtin in a striatal neuronal cell line and in R6/2 mice.
Frederick NM; Bertho J; Patel KK; Petr GT; Bakradze E; Smith SB; Rosenberg PA
Neurochem Int; 2014 Oct; 76():59-69. PubMed ID: 25004085
[TBL] [Abstract][Full Text] [Related]
18. Cystamine and cysteamine prevent 3-NP-induced mitochondrial depolarization of Huntington's disease knock-in striatal cells.
Mao Z; Choo YS; Lesort M
Eur J Neurosci; 2006 Apr; 23(7):1701-10. PubMed ID: 16623826
[TBL] [Abstract][Full Text] [Related]
19. Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells: possible role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in the pathogenesis of Huntington disease.
Quintanilla RA; Jin YN; Fuenzalida K; Bronfman M; Johnson GVW
J Biol Chem; 2008 Sep; 283(37):25628-25637. PubMed ID: 18640979
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor 9 activates anti-oxidative functions of Nrf2 through ERK signalling in striatal cell models of Huntington's disease.
Yusuf IO; Chen HM; Cheng PH; Chang CY; Tsai SJ; Chuang JI; Wu CC; Huang BM; Sun HS; Yang SH
Free Radic Biol Med; 2019 Jan; 130():256-266. PubMed ID: 30391672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
